Askanase, A., Fanouriakis, A., Agustin, L., Dall’Era, M., Mosca, M., & Tanaka, Y. (2025). The Lupus Check 5 Tool: A Practical Approach to Initiating Treatment Reviews in Systemic Lupus Erythematosus. Rheumatology and Therapy. https://doi.org/10.1007/s40744-025-00770-w

Askanase, A. D., Furie, R., Dall’Era, M., Bomback, A. S., Schwarting, A., Zhao, M.-H., Bruce, I. N., Khamashta, M., Rubin, B., Carroll, A., Levy, R. A., van Vollenhoven, R., & Urowitz, M. B. (2025). Disease-Modifying Therapies in Lupus Nephritis: A Narrative Review Evaluating Currently Used Pharmacologic Agents. Rheumatology and Therapy. https://doi.org/10.1007/s40744-025-00752-y

Askanase, A. D., Wright, D., Zhao, E., Zhu, J., Bilyk, R., & Furie, R. A. (2021). Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus. Rheumatology and Therapy, 8(4), 1871–1886. https://doi.org/10.1007/s40744-021-00351-7

Birt, J. A., Hadi, M. A., Sargalo, N., Brookes, E., Swinburn, P., Hanrahan, L., Tse, K., Bello, N., Griffing, K., Silk, M. E., Delbecque, L. A., Kamen, D., & Askanase, A. D. (2021). Patient Experiences, Satisfaction, and Expectations with Current Systemic Lupus Erythematosus Treatment: Results of the SLE-UPDATE Survey. Rheumatology and Therapy, 8(3), 1189–1205. https://doi.org/10.1007/s40744-021-00328-6

Giles, J. T., Simon, L. S., Pope, J., Paik, J. S., Grabner, M., Quebe, A., Kannowski, C. L., Salinas, C. A., & Curtis, J. R. (2021). Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis. Rheumatology and Therapy, 8(3), 1383–1391. https://doi.org/10.1007/s40744-021-00346-4